Author: Colin Pettis

Colin Pettis covers the senior semiconductor sector and is a managing director at Tech Insider, joining in 2012. Colin has 20 years of experience in equity research including 15 years in semiconductor components. Colin is currently responsible for the coverage of 18 large-cap and small-cap semiconductor companies.
Finance

NASDAQ Recent Insider Buying: Synta Pharmaceuticals (NASDAQ:SNTA), Repligen Corporation (NASDAQ:RGEN), Equinix Inc (NASDAQ:EQIX), AspenBio Pharma (NASDAQ:APPY)

Synta Pharmaceuticals Corp. (NASDAQ:SNTA) Director Kovner Bruce purchased 1,250,000 shares of the stock in a transaction that occurred on Friday, April 11th. The shares were purchased at an average cost of $4.01 per share, with a total value of $5,012,500.00. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) stock performance was 1.01% in last session and finished the day at $4.01. Traded volume was 1.90million shares in the last … Continue reading NASDAQ Recent Insider Buying: Synta Pharmaceuticals (NASDAQ:SNTA), Repligen Corporation (NASDAQ:RGEN), Equinix Inc (NASDAQ:EQIX), AspenBio Pharma (NASDAQ:APPY)

Colin Pettis
Finance

Stocks In Bullish Zone: Johnson & Johnson (NYSE:JNJ), QUALCOMM (NASDAQ:QCOM), PepsiCo (NYSE:PEP), Baker Hughes Incorporated (NYSE:BHI)

New Brunswick, N.J.-based Johnson & Johnson (NYSE:JNJ) is probably most famous as the parent company of multiple household products that double as household names. Listing them all would require more space than is practical, but they include Band-Aid, Listerine, Splenda, Stayfree, Lubriderm, Visine, Purell, Mylanta, Bengay, and dozens upon dozens of others. Johnson & Johnson (NYSE:JNJ)’s array of consumer goods isn’t merely wide, but dominant. … Continue reading Stocks In Bullish Zone: Johnson & Johnson (NYSE:JNJ), QUALCOMM (NASDAQ:QCOM), PepsiCo (NYSE:PEP), Baker Hughes Incorporated (NYSE:BHI)

Colin Pettis
Finance

Solar Stocks To Watch; First Solar (NASDAQ:FSLR), NVIDIA Corporation (NASDAQ:NVDA), ARM Holdings (NASDAQ:ARMH), Cirrus Logic (NASDAQ:CRUS)

On March 21, Nevada Business published a photograph showing Reid breaking ground on a project with representatives of the Moapa Band of Paiutes, executives with First Solar Inc. (NASDAQ:FSLR) and representatives of the Los Angeles Department of Water and Power. The 250 megawatt Moapa Southern Paiute Solar Project is planned to deliver renewable energy to the city of Los Angeles for the next 24 years. … Continue reading Solar Stocks To Watch; First Solar (NASDAQ:FSLR), NVIDIA Corporation (NASDAQ:NVDA), ARM Holdings (NASDAQ:ARMH), Cirrus Logic (NASDAQ:CRUS)

Colin Pettis
Finance

Eye-catching Stocks: Nokia Corporation (ADR) (NYSE:NOK), Hanwha Solarone (NASDAQ:HSOL), ReneSola (NYSE:SOL), Yingli Green Energy (ADR) (NYSE:YGE)

Nokia Corporation (ADR) (NYSE:NOK) issued an advisory for customers in the US and parts of Europe warning them of electric shock from a battery charger meant for its Lumia tablet 2520 due to a defect by its vendor. Nokia Corporation (ADR) (NYSE:NOK) stock performance was 0.55% in last session and finished the day at $7.34. Traded volume was 16.55million shares in the last session and … Continue reading Eye-catching Stocks: Nokia Corporation (ADR) (NYSE:NOK), Hanwha Solarone (NASDAQ:HSOL), ReneSola (NYSE:SOL), Yingli Green Energy (ADR) (NYSE:YGE)

Colin Pettis
Finance

Biotech Volatile Stocks: Lexicon Pharmaceuticals (NASDAQ:LXRX), Corcept Therapeutics Incorporated (NASDAQ:CORT), Insys Therapeutics (NASDAQ:INSY), ANI Pharmaceuticals (NASDAQ:ANIP)

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), just announced a positive, top-line result in a Phase 2 clinical trial of their experimental therapy LX4211 in type 1 diabetes. LX4211, an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2, was designed to lower blood glucose levels through two insulin-independent mechanisms of action. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) stock performance was 5.16% in last session and finished the … Continue reading Biotech Volatile Stocks: Lexicon Pharmaceuticals (NASDAQ:LXRX), Corcept Therapeutics Incorporated (NASDAQ:CORT), Insys Therapeutics (NASDAQ:INSY), ANI Pharmaceuticals (NASDAQ:ANIP)

Colin Pettis
Finance

Biotech New Lows: ArQule (NASDAQ:ARQL), OvaScience Inc (NASDAQ:OVAS), Uniqure (NASDAQ:QURE), Egalet Corp (NASDAQ:EGLT)

ArQule Inc. (NASDAQ:ARQL) announced that the Company will present at the Needham 13th Annual Healthcare Conference. The presentation will be web cast and may be accessed through the investor relations section of the Company’s website http://www.arqule.com. ArQule, Inc. (NASDAQ:ARQL) stock performance was -2.92% in last session and finished the day at $1.66. Traded volume was 530,559.00million shares in the last session and the average volume … Continue reading Biotech New Lows: ArQule (NASDAQ:ARQL), OvaScience Inc (NASDAQ:OVAS), Uniqure (NASDAQ:QURE), Egalet Corp (NASDAQ:EGLT)

Colin Pettis